These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27124967)

  • 1. [Management of treatment in patients with neuroendocrine neoplasmas of digestive tract].
    Kinová S; Kovácová M; Caprnda M; Koren M
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S12-20. PubMed ID: 27124967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of treatment in patients with neuroendocrine neoplasmas of digestive tract].
    Kiňová S; Kováčová M; Čaprnda M; Koreň M
    Vnitr Lek; 2015; 61 Suppl 5():12-20. PubMed ID: 26800468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
    Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
    Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
    Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
    Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tumours of the small bowel: interpretation of raised circulating chromogranin A, urinary 5 hydroxy indole acetic acid and circulating neurokinin A.
    Ardill JE; Armstrong L; Smye M; Doherty R; McCance DR; Johnston BT
    QJM; 2016 Feb; 109(2):111-5. PubMed ID: 25979268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.
    Søndenaa K; Sen J; Heinle F; Fjetland L; Gudlaugsson E; Syversen U
    World J Surg; 2004 Sep; 28(9):890-5. PubMed ID: 15593463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.
    Khasraw M; Ananda S; Michael M
    Expert Rev Anticancer Ther; 2016; 16(4):391-401. PubMed ID: 26808925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
    Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
    Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
    Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
    PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame.
    Marotta V; Zatelli MC; Sciammarella C; Ambrosio MR; Bondanelli M; Colao A; Faggiano A
    Endocr Relat Cancer; 2018 Jan; 25(1):R11-R29. PubMed ID: 29066503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors.
    Khan TM; Garg M; Warner RR; Uhr JH; Divino CM
    Pancreas; 2016 Aug; 45(7):1032-5. PubMed ID: 26684860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
    Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
    Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
    Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.
    Han X; Zhang C; Tang M; Xu X; Liu L; Ji Y; Pan B; Lou W
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):527-35. PubMed ID: 25822862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A jejunal stromal tumour in a patient with metastatic neuroendocrine cancer of unknown origin; a rare coexistence, diagnostic and therapeutic challenge.
    El Ali Z; Iwanik K; Sowiński J; Swora E; Grzymislawski M
    Endokrynol Pol; 2009; 60(3):216-20. PubMed ID: 19569023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report.
    Kos-Kudła B; Zemczak A; Foltyn W; Marek B; Strzelczyk J; Telega A; Zajecki W; Legaszewski T; Jurecka-Lubieniecka B
    Endokrynol Pol; 2007; 58(2):123-9. PubMed ID: 17578828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin As a Biochemical Marker of Neuroendocrine Tumors.
    Lyubimova NV; Churikova TK; Kushlinskii NE
    Bull Exp Biol Med; 2016 Mar; 160(5):702-4. PubMed ID: 27021085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromogranin A and neuroendocrine tumors].
    Díaz Pérez JÁ; Currás Freixes M
    Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment options of neuroendocrine tumours].
    Uhlyarik A; Pápai Z
    Orv Hetil; 2013 Sep; 154(39):1549-55. PubMed ID: 24058100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.